Notificação de acontecimentos adversos ou reclamações de qualidade
AZ Medical Global

Áreas Terapêuticas
Medicamentos
Recursos
Conectar

Login

Search Medical Information

Para pesquisar informação científica, deverá especificar pelo menos dois termos de pesquisa

Search Medical Information

CHEST Annual Meeting 2024

October 06 - 09, 2024

AIRSUPRA (albuterol/budesonide)
BREZTRI (budesonide/glycopyrronium/formoterol)
FASENRA (benralizumab)
TEZSPIRE (tezepelumab)

PDF

Lessons from bench to bedside: Exploring genomic and non-genomic mechanisms of albuterol-budesonide as needed for treatment and prevention of acute airway obstruction (ALTA)

PDF

Severe Exacerbations in Patients Following Improved Adherence to Inhaled Corticosteroid-Containing Asthma Maintenance Medications Versus Not: A US Claim-Based Study

HTML

Efficacy of albuterol-budesonide rescue on top of inhaled corticosteroid/long-acting β-agonist (LABA) asthma maintenance therapy containing formoterol or other LABA (MANDALA)

HTML

Efficacy of albuterol-budesonide rescue in patients with moderate-to-severe asthma by smoking history (former vs never): Analysis of MANDALA

PDF

Perspectives on Clinical Discharge Protocols and the Initiation of Single-Inhaler Triple Therapy Following Severe COPD Exacerbations in the United States: An eDelphi Study

PDF

Reduced Risk of Cardiopulmonary Events for COPD Patients Initiating Budesonide/Glycopyrrolate/ Formoterol vs Multiple Inhaler Triple Therapy in the US: The SKOPOS-MAZI Study

PDF

Pulmonary and Cardiovascular Involvement and Persistent Damage in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Analysis of US Health Insurance Claims Data

PDF

Long-term remission and outcomes in patients with severe eosinophilic asthma (SEA) receiving benralizumab: MELTEMI post-hoc analysis

HTML

Efficacy of tezepelumab in patients with severe, uncontrolled asthma and allergic rhinitis grouped by baseline blood eosinophil count: pooled analysis of PATHWAY and NAVIGATOR

HTML

Effect of tezepelumab on patient-reported activity levels and sleep disturbance in patients with severe, uncontrolled asthma: results from the phase 3 NAVIGATOR study

HTML

Efficacy of tezepelumab in adults with moderate to very severe chronic obstructive pulmonary disease by blood eosinophil count and smoking history: phase 2a COURSE study

Não encontra o que procura?

Contacte-nos

Encontre um Medical Healthcare Partner

Submeter uma questão

A informação incluída neste website é dirigida exclusivamente a profissionais de saúde.

©2024 AstraZeneca. Todos os direitos reservados. PT-19636

Aprovado a 12/2024.

Sobre o AZMedical

AstraZeneca Portugal

Inquérito de Satisfação

Política de Privacidade

Aviso Legal e Termos de Utilização

Notificação de acontecimentos adversos ou reclamações de qualidade

Política de Privacidade

Aviso Legal e Termos de Utilização